Abstract:Cancer, as a conundrum, is currently the biggest killer of human health. The major viewpoint of carcinogenesis is owing to somatic gene mutations. Based on such a viewpoint and the development of gene sequencing technology, extensive genomic alterations in cancer genomes have been identified. How to develop a better understanding of the link between gene mutations and carcinogenesis as well as efficient clinical cancer therapy is therefore a major challenge. Weinberg and Hanahan have suggested 10 hallmarks of cancer. The hallmarks are highly regulated by the corresponding signaling pathways. Thus, cancer itself is also a disease of dysfunction of signal transduction pathways related to multiple fundamental cell processes, including proliferation, differentiation, apoptosis, invasion and so on. Despite the signaling pathways are extremely complex in cancer cells, one can still focus on the signaling networks that govern the corresponding cell processes for modeling to discuss its dynamics and regulation functions quantitatively. Systems biology provides appropriate approach to integrate the experimental data (clinical data) and signaling pathway for a comprehensive analysis, resulting in a further prediction for optimal therapy and drug discovery. In this paper, we review the recent progress of dynamical modeling of signaling networks by using systems biology approaches that help to exploring the mechanisms of carcinogenesis. We first discuss the motif dynamics of the signaling networks. The presented generic circuit model can be decomposed into two loops and the circuit can achieve tristability through four kinds of bifurcation scenarios when parameter values are varied in a wide range. Then, we show the relative well-studied core signaling networks that regulate the cell survival, apoptosis, proliferation, invasion and energy metabolism processes. For each fundamental cell process, we individually review the dynamics of corresponding signaling network based on the systems biology approaches, including the NF-B signaling pathway that regulates the cell survival process, the Ras signaling pathway that governs the cell proliferation process, the EMT and mitochondrial signaling pathway that modulate the cell invasion and apoptosis processes. Furthermore, two coupled signaling networks, i.e., the p53 and TNF- signaling networks are discussed. Lastly, we review the breast cancer and gastric cancer signaling networks which contain several fundamental cell processes. The potential contribution for cancer treatment is also suggested. These dynamical modeling based on the core signaling networks can facilitate the understanding of the mechanisms of carcinogenesis and provide us the possible clues and ideas of the cancer treatment and drug design. We believe more exciting research works in this field will be stimulated in the near future.

What We Have Learnt from Drosophila Model Organism: the Coordination Between Insulin Signaling Pathway and Tumor Cells

Drosophila melanogaster: A Model Organism to Study Cancer

Tumor models in various Drosophila tissues

Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy

Insulin and Hypoxia-Inducible Factor-1 Cooperate in Pancreatic Cancer Cells to Increase Cell Viability.

Insulin Upregulates FHOD1 Expression and Promotes the Invasion and Migration of Pancreatic Cancer Ccells Via Insulin Receptor-Dependent EMT Activation

Insulin Promotes Proliferation of Pancreatic Ductal Epithelial Cells by Increasing Expression of PLK1 Through PI3K/AKT and NF-κB Pathway.

Using Drosophila to uncover the role of organismal physiology and the tumor microenvironment in cancer

A Tumor-Specific Molecular Network Promotes Tumor Growth in Drosophila by Enforcing a Jun N-Terminal Kinase–Yorkie Feedforward Loop

Roles of the insulin signaling pathway in insect development and organ growth

Transforming growth factor-beta signaling, a potential mechanism associated with diabetes mellitus and pancreatic cancer?

Insulin, insulin receptors, and cancer

Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities

The Involvement of the Mammalian Target of Rapamycin, Protein Tyrosine Phosphatase 1b and Dipeptidase 4 Signaling Pathways in Cancer and Diabetes: A Narrative Review

Sex-dimorphic tumor growth is regulated by tumor microenvironmental and systemic signals

Cdc42: A Novel Regulator of Insulin Secretion and Diabetes-Associated Diseases

Oncogenic Activity of Insulin in the Development of Non-Small Cell Lung Carcinoma

Advances in Targeting Insulin-Like Growth Factor Signaling Pathway in Cancer Treatment.

Dynamical Studies of Cellular Signaling Networks in Cancers

Network based approach to identify interactions between Type 2 diabetes and cancer comorbidities

Diabetes and cancer relationships.